Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.

about

Association between prolonged neutropenia and reduced relapse risk in pediatric AML: A report from the children's oncology group.

Item

http://www.wikidata.org/entity/Q42585707

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Association between prolonged ...... the children's oncology group.

@en

Association between prolonged ...... the children's oncology group.

@nl

type

Item

label

Association between prolonged ...... the children's oncology group.

@en

Association between prolonged ...... the children's oncology group.

@nl

prefLabel

Association between prolonged ...... the children's oncology group.

@en

Association between prolonged ...... the children's oncology group.

@nl

P1476

Association between prolonged ...... the children's oncology group.

@en

P2093

Alan S Gamis

http://www.w3.org/2001/XMLSchema#string

Lillian Sung

http://www.w3.org/2001/XMLSchema#string

Richard Aplenc

http://www.w3.org/2001/XMLSchema#string

Robert B Gerbing

http://www.w3.org/2001/XMLSchema#string

Soheil Meshinchi

http://www.w3.org/2001/XMLSchema#string

Todd A Alonzo

http://www.w3.org/2001/XMLSchema#string

Yi-Cheng Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The clinically relevant pharmacogenomic changes in acute myelogenous leukemia

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.

Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.

The relationship of polymorphisms in ABCC2 and SLCO1B3 with docetaxel pharmacokinetics and neutropenia: CALGB 60805 (Alliance).

Children's Oncology Group (COG) Nutrition Committee.

Pharmacogenomics in acute myeloid leukemia.

Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia.

International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia.

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.

Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin.

P304

1930-1935

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.30236

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27312107

http://www.w3.org/2001/XMLSchema#string

P932

4990479

http://www.w3.org/2001/XMLSchema#string